(VIANEWS) – The NASDAQ ended the session with Sorrento Therapeutics (SRNE) rising 7.93% to $2.25 on Wednesday while NASDAQ fell 0.15% to $11,053.08.
Volume
Today’s last reported volume for Sorrento Therapeutics is 29026500, 214.38% above its average volume of 9232820.
Sorrento Therapeutics’s last close was $2.08, 81.21% below its 52-week high of $11.07.
Sorrento Therapeutics’s Sales
Sorrento Therapeutics’s sales growth is 29% for the present quarter and 85.1% for the next. The company’s growth estimates for the ongoing quarter is a negative 1700% and positive 77.2% for the next.
Sorrento Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 52.9M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Sorrento Therapeutics’s stock is considered to be oversold (<=20).
Sorrento Therapeutics’s Stock Yearly Top and Bottom Value
Sorrento Therapeutics’s stock is valued at $2.25 at 18:33 EST, way below its 52-week high of $11.07 and way above its 52-week low of $1.15.
Sorrento Therapeutics’s Moving Average
Sorrento Therapeutics’s value is way higher than its 50-day moving average of $1.70 and way below its 200-day moving average of $4.40.
More news about Sorrento Therapeutics (SRNE).
